4.4 Article

Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer

Journal

FUTURE ONCOLOGY
Volume 18, Issue 7, Pages 793-805

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/fon-2021-1130

Keywords

biomarkers; colorectal cancer; CRC diagnosis; early-stage; exosomal miR-377-3p; exosomal miR-381-3p; exosome; miRNAs; serum

Categories

Funding

  1. National Natural Science Foundation of China [81773237]
  2. Shandong Provincial Natural Science Foundation [ZR2020LZL017]

Ask authors/readers for more resources

This study identified downregulated exosomal miR-377-3p and miR-381-3p in CRC patients, serving as circulating biomarkers for the diagnosis of CRC, especially for early-stage detection.
Aim: This study aimed to identify specific and sensitive exosomal miRNAs in diagnosing patients with colorectal cancer (CRC). Methods: Serum exosomes were isolated from 175 CRC patients and 172 healthy donors by ultracentrifugation and identified by transmission electron microscopy, nanoparticle tracking analysis and western blotting. Exosomal miRNA expression was detected by qPCR and the results analyzed by receiver operating characteristic analysis to illuminate the diagnostic accuracy. Results: Both exosomal miR-377-3p and miR-381-3p were downregulated in CRC patients as well as in early-stage patients compared with healthy donors; they could serve as circulating biomarkers of diagnosis, including early diagnosis, for CRC, possessing favorable diagnostic efficiency. Conclusion: Exosomal miR-377-3p and miR-381-3p levels were downregulated in CRC patients and may be useful as novel and specific biomarkers for the diagnosis of CRC, especially early-stage CRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available